Allouch, Awatef http://orcid.org/0000-0003-1232-0629
Voisin, Laurent
Zhang, Yanyan
Raza, Syed Qasim
Lecluse, Yann
Calvo, Julien http://orcid.org/0000-0003-1316-4306
Selimoglu-Buet, Dorothée http://orcid.org/0000-0002-3565-2709
de Botton, Stéphane
Louache, Fawzia
Pflumio, Françoise http://orcid.org/0000-0001-8995-596X
Solary, Eric http://orcid.org/0000-0002-8629-1341
Perfettini, Jean-Luc http://orcid.org/0000-0002-2427-2604
Article History
Received: 6 May 2021
Accepted: 28 October 2022
First Online: 8 November 2022
Competing interests
: A.A. and J.-L.P. are listed as co-inventors on a patent application related to p21TD-Mo-based cellular therapy (p21 expressing monocytes for cancer cell therapy, WO2021013764). J.-L.P. is a founding member of Findimmune SAS, an immuno-oncology biotech company. J.-L.P. discloses research funding not related to this work from NH TherAguix SAS. The remaining authors declare no competing interests.